Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 HKD | 0.00% | +4.52% | -48.47% |
Apr. 30 | Transcenta Holding Limited Announces Board and Nomination Changes | CI |
Apr. 09 | Transcenta Partners with Agilent to Develop Claudin18.2 Companion Diagnostic | MT |
Business Summary
Number of employees: 215
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oncology and Non-oncology Therapeutics
100.0
%
| 118 | 100.0 % | 60 | 100.0 % | -49.78% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 118 | 100.0 % | 60 | 100.0 % | -49.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Xue Ming Qian
FOU | Founder | 57 | 10-07-31 |
Xiao Lu Weng
DFI | Director of Finance/CFO | 47 | 21-12-16 |
Caroline Germa
CTO | Chief Tech/Sci/R&D Officer | 52 | 22-08-07 |
Charlie Qi
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Yi Gu
CTO | Chief Tech/Sci/R&D Officer | 55 | 19-01-31 |
Ming Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | - |
Chief Tech/Sci/R&D Officer | 61 | 16-09-30 | |
Feng Ye
COO | Chief Operating Officer | 57 | 15-12-31 |
Wei Wang
IRC | Investor Relations Contact | 41 | 22-03-20 |
Agnes Dai
HRO | Human Resources Officer | - | 20-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Ning Zhao
FOU | Founder | 53 | 18-11-30 |
Xue Ming Qian
FOU | Founder | 57 | 10-07-31 |
Jia Song Tang
BRD | Director/Board Member | 50 | 21-09-13 |
Zhi Hua Zhang
BRD | Director/Board Member | 43 | 21-09-13 |
Ming Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | - |
Kumar Srinivasan
BRD | Director/Board Member | 59 | 22-12-18 |
Xiao Lu Weng
DFI | Director of Finance/CFO | 47 | 21-12-16 |
Wei Chen
BRD | Director/Board Member | 57 | 23-08-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 436,375,375 | 391,490,827 ( 89.71 %) | 0 | 89.71 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.47% | 96.31M | |
+37.76% | 705B | |
+32.82% | 583B | |
-3.66% | 364B | |
+20.25% | 332B | |
+5.05% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.95% | 169B |
- Stock Market
- Equities
- 6628 Stock
- Company Transcenta Holding Limited